Risk of virological failure after drug burden reduction in non-viremic people with 4-class drug-resistant HIV: data from the PRESTIGIO Registry
EACS eAcademy. Clemente T. 10/20/23; 4201123
Topic: Virological failure and drug resistance
Already Registered? Request your Direct Access
PREMIUM CONTENT
PREMIUM CONTENT
Access to Premium content is currently an EACS membership benefit.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}